Self-efficacy and self-management strategies in acute intermittent porphyria

Table 2 General self-efficacy scale (GSES); total and subgroup scores and differences among subgroup scores

Score range 10–40
	n	Median (IQR)	p ^a
GSES total	136	31.0 (29.0, 35.0)
Women	79	31.0 (28.0, 35.0)	0.34
Men	57	32.0 (29.0, 35.5)	0.34
Asymptomatic HMBS carriers^b	28	30.0 (29.3, 34.0)	0.86
Symptomatic HMBS carriers^b	102	32.0 (29.0, 35.0)	0.86
Unclassified	6

IQR interquartile range (i.e., 25th, 75th percentiles)
^a By Mann–Whitney nonparametric U test
^b Categorization into symptomatic and asymptomatic HMBS mutation carriers was based on self-assessment by the study participants

ISSN: 1472-6963